ICASA aims to contribute to a substantial decrease in the proportion of ADHD patients developing an addiction/substance use disorder (SUD) and to substantially improve the detection, diagnosis and treatment of patients having both ADHD and SUD.

Highlights on website

Latest publication

The MINI-Plus may be used for the screening of ADHD in SUD patients. This is the result of a novel paper based on ICASA-research

Read article

Next event

All events

Selected evidence

A collection of relevant literature regarding the topic of ADHD and Substance abuse disorder comborbidity. Regularly updated to present the most recent scientific insights.

Publications

Latest news

European Addiction Research released the Special Topic Issue on ADHD-Addiction (Vol. 26, No. 4-5, 2020). You will find an editorial, a review on history and future of ICASA projects, the consensus statement on ADHD-Addiction in adolescents, a review on Continuous Performance Tests for diagnosing ADHD in Substance Use Disorders patients, and ten new research articles on ADHD-Addiction. Please visit: https://www.karger.com/Journal/Issue/279180.
You will find the International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder via this link (Open Access): https://www.karger.com/Article/Pdf/508385.

ICASA Research

Stakeholders of ICASA

Members

If you are a member: find all the information about our network on this website: inclusion of subjects in the incas study, upcoming icasa meetings, events etcetera. If you consider to participate: look around and contact us.

Treatment providers

If you are working as a treatment provider in the field of ADHD, general psychiatry and/or addiction, you may work with patients suffering from Substance Use Disorders comorbidity. Keep your knowledge up to date with the latest insights gathered on one website.

world map

Contact details of ICASA